This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$40.88
US$ Class I Dist
NAV per share 29.07.2021
€1,256mAUM

AUM 30.06.2021

Holdings
72.11% Active Share
As at 30.06.2021